In Silico Approaches for Drug Repurposing for SARS-Co V-2 Infection; Vaccination and Vaccines for COVID-19; Understanding Emergence of SARS-Co V-2 Viral Variants from a Genomic Perspective; Susceptibility and Spread of SARS-Cov-2 in Animals; Profiling Some Plant-based Immunomodulatory Bioactive Compounds for COVID-19 Prophylaxis and Treatment Based on Indian Traditional Medicine; The Potential Therapeutic effects of Natural Products, Herbs, Mushrooms Against COVID-19; Application of Chinese Herbal Medicine in COVID-19; COVID-19 Interventional and Therapeutic Clinical Trials: Small Molecules, Interactions, Outcomes and Opportunities; A Trend Analysis of COVID-19 Pandemic in Turkey; The Swedish Approach to COVID-19; New Zealand’s Response to the First Wave of COVID-19; Significant SARS-Co V-2 Variants Circulating Around the World: Origin, Spread and Phylodynamics; Survival of SARS-Co V-2 Outside the Body and Methods of Disinfection; U.S. Regulatory Approaches to Disinfectants for Coronavirus; Diagnostic Strategies for Early and Point-of-care Detection of COVID-19 in Clinical and Personalized Settings; Human Resource Management, Preparedness and Outcomes; Role of Telehealth during the COVID-19 Pandemic; Medical Education During the Covid Pandemic: Challenges and Solutions; Containment Strategies to Prevent Spread in Different Societies and Cultures; Effective Health Education, Patient Education, Health Behaviour Change; Strengthening the Biological and Toxin Weapons Convention after COVID-19: Reaching Agreement on a Code of Conduct and Biological Security Education at the 2021 9th Review Conference; COVID-19 Prevention; Human Response to Pandemics in History and Medico-anthropological Correlates; The COVID-19 Pandemic – Global Lessons for the Future

Michael D. Waters, holds a Ph.D. in Biochemistry from the University of North Carolina School of Medicine at Chapel Hill and a B.S. in Pre-medicine (Chemistry and Biology) from Davidson College. He is a former government scientist with more than 35 years of experience in research and research management positions at EPA and NIH/NIEHS and six years of private sector experience as Chief Scientific Officer at Integrated Laboratory Systems, Inc. His research interests have centered on the evaluation of chemically-induced mutations and altered molecular expression in the etiology of genetic disease. He is a widely-published scientist having published well over 100 peer-reviewed in authoritative international scientific journals. He has edited Mutation Research-Reviews for nearly 20 years and has held adjunct professorships at both the University of North Carolina and at Duke University for many years. He served as President of both the Environmental Mutagen Society and the International Association of Environmental Mutagen Societies (now the Environmental Mutagenesis and Genomics Society and the International Association of Environmental Mutagenesis and Genomics Societies, with more than seven thousand members worldwide). The databases he has developed and a number of his publications are recognized as important advances that have significantly impacted the fields of genetic toxicology, carcinogenesis, toxicogenomics, and risk assessment.